C10orf118 is a protein that in humans is encoded by the C10orf118 gene[2] The C10orf118 (CCDC186) gene is also known as the CTCL-tumor associated antigen with accession number NM_018017.[3]
C10orf118 has the chromosome location of 10q25.3 and is 53,750 bases in size oriented on the minus strand. PSORTII Protein k-NN Prediction indicated that C10orf118 is 65.2% of the time nuclear, 17.4% cytosolic, 8.7% mitochondrial, 4.3% vesicles of secretory system, and 4.3% endoplasmic reticulum.[4]
Expression
Analysis of gene expression in humans and other species indicates C10orf118 is ubiquitously expressed in all tissue types at varying developmental stages. An EST profile from NCBI displayed the greatest expression in bone marrow, kidneys, and the prostate cell lines. Breakdown by health state indicates high expression of C10orf118 in bladder carcinoma and prostate cancer.[7]
A serine rich region is observed in amino acids 710-747. A compositional analysis revealed that C10orf118 is Proline (1.1%) poor and Glutamic acid (14.1%) and Lysine (12.0%) rich.[8]
Interactions
C10orf118 protein was found to interact with proteins PLEKAH5, Ezra, GAMMAHV.ORF23, and SMAD3.[9][10]
Homology
Orthologous sequences of C10orf118 were not found to be in bacteria, archea, protist, or plants. C10orf118 has no human paralogs. The date of divergence for the orthologous sequences highly correlates with the sequences similarity in that the percent identity decreases as you go back in time. Closely related orthologs include mammals and birds and moderately related orthologs include other vertebrates such as fish, reptiles, and amphibians. Distantly related orthologous sequences are primarily observed in invertebrates.[8][12]
Prior research indicates that the open reading frame of C10orf118 is linked to cutaneous T-cell lymphoma by a tumor antigen L14-2.[15] The protein C10orf118 is also found at higher than normal levels in the breast cancer cell line BC 8701.[16]
↑D’Angelo, M. L. (2013). "Identification of the "Uncharacterized Protein C10orf118" in Breast Cancer Cells and Its Role on the Hyaluronan Metabolism". Matrix Pathobiology, Signaling and Molecular Targets.
Hartmann TB, Thiel D, Dummer R, Schadendorf D, Eichmüller S (February 2004). "SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma". The British Journal of Dermatology. 150 (2): 252–8. doi:10.1111/j.1365-2133.2004.05651.x. PMID14996095.